• Je něco špatně v tomto záznamu ?

Generic Platform for the Multiplexed Targeted Electrochemical Detection of Osteoporosis-Associated Single Nucleotide Polymorphisms Using Recombinase Polymerase Solid-Phase Primer Elongation and Ferrocene-Modified Nucleoside Triphosphates

M. Ortiz, M. Jauset-Rubio, O. Trummer, I. Foessl, D. Kodr, JL. Acero, ML. Botero, P. Biggs, D. Lenartowicz, K. Trajanoska, F. Rivadeneira, M. Hocek, B. Obermayer-Pietsch, CK. O'Sullivan

. 2023 ; 9 (8) : 1591-1602. [pub] 20230719

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015410

Osteoporosis is a multifactorial disease influenced by genetic and environmental factors, which contributes to an increased risk of bone fracture, but early diagnosis of this disease cannot be achieved using current techniques. We describe a generic platform for the targeted electrochemical genotyping of SNPs identified by genome-wide association studies to be associated with a genetic predisposition to osteoporosis. The platform exploits isothermal solid-phase primer elongation with ferrocene-labeled nucleoside triphosphates. Thiolated reverse primers designed for each SNP were immobilized on individual gold electrodes of an array. These primers are designed to hybridize to the SNP site at their 3'OH terminal, and primer elongation occurs only where there is 100% complementarity, facilitating the identification and heterozygosity of each SNP under interrogation. The platform was applied to real blood samples, which were thermally lysed and directly used without the need for DNA extraction or purification. The results were validated using Taqman SNP genotyping assays and Sanger sequencing. The assay is complete in just 15 min with a total cost of 0.3€ per electrode. The platform is completely generic and has immense potential for deployment at the point of need in an automated device for targeted SNP genotyping with the only required end-user intervention being sample addition.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015410
003      
CZ-PrNML
005      
20231020093532.0
007      
ta
008      
231010s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acscentsci.3c00243 $2 doi
035    __
$a (PubMed)37637735
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ortiz, Mayreli $u INTERFIBIO Research Group, Departament d'Enginyeria Química, Universitat Rovira i Virgili, 43007 Tarragona, Spain $1 https://orcid.org/0000000294230055
245    10
$a Generic Platform for the Multiplexed Targeted Electrochemical Detection of Osteoporosis-Associated Single Nucleotide Polymorphisms Using Recombinase Polymerase Solid-Phase Primer Elongation and Ferrocene-Modified Nucleoside Triphosphates / $c M. Ortiz, M. Jauset-Rubio, O. Trummer, I. Foessl, D. Kodr, JL. Acero, ML. Botero, P. Biggs, D. Lenartowicz, K. Trajanoska, F. Rivadeneira, M. Hocek, B. Obermayer-Pietsch, CK. O'Sullivan
520    9_
$a Osteoporosis is a multifactorial disease influenced by genetic and environmental factors, which contributes to an increased risk of bone fracture, but early diagnosis of this disease cannot be achieved using current techniques. We describe a generic platform for the targeted electrochemical genotyping of SNPs identified by genome-wide association studies to be associated with a genetic predisposition to osteoporosis. The platform exploits isothermal solid-phase primer elongation with ferrocene-labeled nucleoside triphosphates. Thiolated reverse primers designed for each SNP were immobilized on individual gold electrodes of an array. These primers are designed to hybridize to the SNP site at their 3'OH terminal, and primer elongation occurs only where there is 100% complementarity, facilitating the identification and heterozygosity of each SNP under interrogation. The platform was applied to real blood samples, which were thermally lysed and directly used without the need for DNA extraction or purification. The results were validated using Taqman SNP genotyping assays and Sanger sequencing. The assay is complete in just 15 min with a total cost of 0.3€ per electrode. The platform is completely generic and has immense potential for deployment at the point of need in an automated device for targeted SNP genotyping with the only required end-user intervention being sample addition.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jauset-Rubio, Miriam $u INTERFIBIO Research Group, Departament d'Enginyeria Química, Universitat Rovira i Virgili, 43007 Tarragona, Spain $1 https://orcid.org/0000000299436132
700    1_
$a Trummer, Olivia $u Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria
700    1_
$a Foessl, Ines $u Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria
700    1_
$a Kodr, David $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo namesti 2, CZ 16610 Prague 6, Czech Republic $1 https://orcid.org/0000000259486426
700    1_
$a Acero, Josep Lluís $u INTERFIBIO Research Group, Departament d'Enginyeria Química, Universitat Rovira i Virgili, 43007 Tarragona, Spain
700    1_
$a Botero, Mary Luz $u INTERFIBIO Research Group, Departament d'Enginyeria Química, Universitat Rovira i Virgili, 43007 Tarragona, Spain
700    1_
$a Biggs, Phil $u Labman Automation Ltd., Seamer Hill, Stokesley, North Yorkshire, TS9 5NQ U.K
700    1_
$a Lenartowicz, Daniel $u Labman Automation Ltd., Seamer Hill, Stokesley, North Yorkshire, TS9 5NQ U.K
700    1_
$a Trajanoska, Katerina $u Department of Internal Medicine, Erasmus MC, 40 3015 Rotterdam, The Netherlands
700    1_
$a Rivadeneira, Fernando $u Department of Internal Medicine, Erasmus MC, 40 3015 Rotterdam, The Netherlands
700    1_
$a Hocek, Michal $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo namesti 2, CZ 16610 Prague 6, Czech Republic $u Department of Organic Chemistry, Faculty of Science, Charles University, Hlavova 8, CZ-12843 Prague 2, Czech Republic
700    1_
$a Obermayer-Pietsch, Barbara $u Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria
700    1_
$a O'Sullivan, Ciara K $u INTERFIBIO Research Group, Departament d'Enginyeria Química, Universitat Rovira i Virgili, 43007 Tarragona, Spain $u Institució Catalana de Recerca i Estudis Avancats (ICREA), 08010 Barcelona, Spain $1 https://orcid.org/0000000326032230
773    0_
$w MED00193485 $t ACS central science $x 2374-7943 $g Roč. 9, č. 8 (2023), s. 1591-1602
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37637735 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093526 $b ABA008
999    __
$a ok $b bmc $g 1997132 $s 1201772
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 9 $c 8 $d 1591-1602 $e 20230719 $i 2374-7943 $m ACS central science $n ACS Cent Sci $x MED00193485
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Možnosti archivace